Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    23190221 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
Conditions: Chronic Myelogenous Leukemia;   Hematologic Malignancies
Intervention: Drug: Ponatinib

Study has passed its completion date and status has not been verified in more than two years.